World Journal of Nephrology and Urology, ISSN 1927-1239 print, 1927-1247 online, Open Access
Article copyright, the authors; Journal compilation copyright, World J Nephrol Urol and Elmer Press Inc
Journal website http://www.wjnu.org

Short Communication

Volume 8, Number 1, March 2019, pages 14-16


Cancer Antigen 125 and Nephrotic Syndrome

Figure

Figure 1.
Figure 1. Follow-up of patients with nephrotic syndrome and a level of CA-125 ≥ 35 U/mL at admission and during the period of study. The level was checked once a month, which was discontinued once a normal value of CA-125 (≤ 35 U/mL) was reached.

Table

Table 1. Clinical Parameters, Histopathology, and Laboratory Variables (Media) in Nephrotic Syndrome and CA-125
 
VariableAt admission (n = 19)CA 125 (U/mL) (median)IQR (interquartile range)PCorrelation coefficient
Age (years)45--NS
Gender
  Male1357854 - 1,3820.726
  Female620239 - 1,385
Urine output
  Normal74534 - 2030.004
  Oliguria12797411 - 1,561
  Anuria0
Edema1757859 - 1,3820.063
Ascites71,501727 - 1,7790.001
Laboratory
  Albumin (g/dL)1.9< 0.001-0.8
  Total Cholesterol (mg/dL)4600.0010.6
  Triglyceride (mg/dL)4490.2070.3
  Creatinine (mg/dL)2.360.0120.5
  Urea (mg/dL)790.2560.2
  Proteinuria (mg/24 h)12,4120.3140.2
  VSG (mm/h)1000.340.3